Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026)
Baxter International's (BAX) quarterly Total Non-Current Liabilities came in at $12.4 billion in Q2 2026, down 1.91% year-over-year from $12.7 billion in Q2 2025, and down 0.99% quarter-over-quarter from $12.5 billion in Q1 2026.
Analysis
Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Total Non-Current Liabilities for 18 consecutive years, with $12.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 1.91% year-over-year to $12.4 billion in Q2 2026; TTM through Jun 2026 was $12.4 billion, a 1.91% decrease from a year earlier, with the FY2025 full-year figure at $12.7 billion, down 28.37% from the prior year.
- Total Non-Current Liabilities was $12.4 billion for Q2 2026 at Baxter International, down from $12.5 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $21.2 billion in Q1 2022 and troughed at $12.4 billion in Q2 2026.
- A 5-year average of $17.2 billion and a median of $17.8 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities soared 126.58% in 2022 and dropped 28.37% in 2025, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $20.5 billion in 2022, then declined by 10.4% to $18.4 billion in 2023, then decreased by 3.94% to $17.7 billion in 2024, then retreated by 28.37% to $12.7 billion in 2025, then fell by 1.99% to $12.4 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $12.4 billion (Q2 2026), $12.5 billion (Q1 2026), and $12.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 23.92 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 17.56 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 996.30 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 12.41 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -89.27 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 75.19 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | - |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 13.70 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 4.54 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 333,758.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.41 Bn |
| Mar 31, 2026 | 12.54 Bn |
| Dec 31, 2025 | 12.67 Bn |
| Sep 30, 2025 | 12.73 Bn |
| Jun 30, 2025 | 12.66 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 17.68 Bn |
| Sep 30, 2024 | 17.47 Bn |
| Jun 30, 2024 | 17.01 Bn |
| Mar 31, 2024 | 17.90 Bn |
| Dec 31, 2023 | 18.41 Bn |
| Sep 30, 2023 | 20.71 Bn |
| Jun 30, 2023 | 20.63 Bn |
| Mar 31, 2023 | 20.50 Bn |
| Dec 31, 2022 | 20.54 Bn |
| Sep 30, 2022 | 20.32 Bn |
| Jun 30, 2022 | 20.66 Bn |
| Mar 31, 2022 | 21.16 Bn |
| Dec 31, 2021 | 21.91 Bn |
| Sep 30, 2021 | 9.37 Bn |